Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has.

Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire model. He thinks the opportunity starts there: trim the portfolio, stop chasing every trend, tighten the supply chain, lean on the science, and align operations. Germany's market could nearly double in the next two years, but capturing it will take more than expansion.

This week we sit down with James Yamanaka, CEO of Organigram:

A BAT perspective on cannabis
Why chasing every trend loses money
How the Sanity deal unlocks Germany

Chapters:

00:00 Introduction to Organigram and BAT's Involvement

05:24 Shifting Perspectives: From BAT to Organigram

09:08 Understanding the Complexity of the Cannabis Market

13:12 Balancing Listening and Leadership

17:24 Data-Driven Decision Making in Cannabis

21:18 Strategic SKU Management and Market Forecasting

24:17 Leveraging BAT's Expertise in Cannabis

30:04 The Strategic Importance of the Sanity Deal

39:57 Navigating Regulatory Challenges in the Cannabis Industry

Guest Links:

https://www.linkedin.com/in/james-yamanaka-aaa32a/
https://www.organigram.ca/

Our Links:

Bryan Fields on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

James Yamanaka

Episodes with James Yamanaka